BD unveils first-of-its-kind cell-sorting technology
BD is unveiling its new cell-sorting technology at the June 3-7 International Society for Advancement of Cytometry CYTO 2022 conference.
Stay updated with breaking news from Babson Diagnostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BD is unveiling its new cell-sorting technology at the June 3-7 International Society for Advancement of Cytometry CYTO 2022 conference.
A bear market can test investors' patience, but these companies can help you survive.
A partnership between BD, based in Franklin Lakes, and Babson Diagnostics of Austin aims to make blood-sample collection more convenient.
Vaccine Delivery Devices Market Business Opportunity and Future Growth Analysis Report 2027
Share this article Share this article NEW YORK, July 5, 2021 /PRNewswire/ -- The enzyme-linked immunosorbent assay (ELISA) testing market is expected to grow by USD 265.55 million during 2021-2025, according to Technavio. The report offers a detailed analysis of the impact of the COVID-19 pandemic on the market in optimistic, probable, and pessimistic forecast scenarios. Enterprises will go through the Response, Recovery, and Renew phases. Technavio has announced its latest market research report titled Enzyme-linked Immunosorbent Assay (Elisa) Testing Market by End-user and Geography - Fo...